Skip to main content

Find Clinical Trials

Clinical trial condition

HIV

Explore clinical trials studying HIV. Study availability and eligibility vary by location and protocol.

1,779 public trials 195 recruiting studies

Refine in advanced search Browse all conditions

HIV trial results

Completed

Targeting Interventions at Venues Where Risk of HIV Transmission is High

NCT01423357

Conditions: HIV
Locations: Dambwa Livingstone, Zambia

Maramba Livingstone, Zambia

View Trial Details

Completed

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

NCT00255099

Conditions: HIV
Locations: Not specified

View Trial Details

Completed

TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.

NCT00650832

Conditions: HIV
Locations: Not specified

View Trial Details

Completed

TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.

NCT00767117

Conditions: HIV
Locations: Not specified

View Trial Details

Completed

TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.

NCT00740389

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +18 more
Locations: Not specified

View Trial Details

Completed

TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.

NCT00744887

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Not specified

View Trial Details

Completed

TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.

NCT00828815

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

NCT00315432

Conditions: Anemia, Blood-Borne Infections, Communicable Diseases, +21 more
Locations: Not specified

View Trial Details

Completed

EuroSIDA As An External Comparator To MOTIVATE Trials

NCT01329783

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Not specified

View Trial Details

Completed

The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet

NCT00766818

Conditions: HIV, Pregnancy
Locations: University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details